Skip to main content

Table 2 Operative data and pathological results of patients

From: Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study

Characteristics

NSA group

SA group

P-value

n = 218

n = 232

Duration of operation

  

0.672

 Mean (SD), min

229.3 (46.4)

242.1 (37.8)

 

Estimated blood loss

  

0.374

 Mean (SD), ml

248.3 (215.8)

267.6 (189.2)

 

Intraoperative blood transfusion

35 (16.1)

41 (17.7)

0.647

Extent of resection

  

0.117

 Distal subtotal

137 (62.8)

162 (69.8)

 

 Total

81 (37.2)

70 (30.2)

 

Margin of resection

  

0.014

 R0

208 (95.4)

207 (89.2)

 

 R1 or R2

10 (4.6)

25 (10.8)

 

LNs resected

  

0.805

 Mean (SD)

31 (10)

33 (15)

 

Excised tumor size (cm)

  

0.038

 Mean (SD)

3.9 (1.7)

5.3 (2.1)

 

Lymphovascular invasion

59 (27.1)

75 (32.3)

0.222

Pathological T stage

  

< 0.001

 T0

18 (8.3)

0 (0.0)

 

 T1

24 (11.0)

12 (5.2)

 

 T2

34 (15.6)

18 (7.8)

 

 T3

101 (46.3)

114 (49.1)

 

 T4a

28 (12.8)

45 (19.4)

 

 T4b

13 (6.0)

43 (18.5)

 

Pathological N stage

  

< 0.001

 N0

127 (58.3)

70 (30.2)

 

 N1

41 (18.8)

62 (26.7)

 

 N2

30 (13.8)

50 (21.6)

 

 N3a

16 (7.3)

31 (13.4)

 

 N3b

4 (1.8)

19 (8.2)

 

Distant metastasis

  

< 0.001

 M0

212 (97.2)

203 (87.5)

 

 M1

6 (2.8)

29 (12.5)

 

Pathological TNM stage

  

< 0.001

 0

18 (8.3)

0 (0.0)

 

 I

36 (16.5)

22 (9.5)

 

 II

80 (36.7)

49 (21.1)

 

 III

78 (35.8)

132 (56.9)

 

 IV

6 (2.8)

29 (12.5)

 
  1. Values are presented as number (%) unless otherwise indicated. NSA: neoadjuvant chemotherapy plus surgery plus adjuvant chemotherapy; SA: surgery plus adjuvant chemotherapy; LNs: lymph nodes; SD: standard deviation